Literature DB >> 2943306

Levels of some purine metabolizing enzymes in lymphocytes from patients with Down's syndrome.

R Puukka, M Puukka, L Perkkilä, K Kouvalainen.   

Abstract

The activities of a number of purine metabolizing enzymes of erythrocytes and lymphocytes were determined in 18 subjects with Down's syndrome and in 18 age- and sex-matched control subjects. An increase of adenosine deaminase activity (adenosine or deoxyadenosine as substrates) was found in erythrocytes (P less than 0.001) as well as in lymphocytes (P less than 0.001) of Down's syndrome subjects compared to controls. The purine nucleoside phosphorylase activities in lymphocytes and plasma urate concentrations were also significantly higher in Down's syndrome subjects than in controls (P less than 0.001 and less than 0.02, respectively). Adenine phosphoribosyltransferase activities and hypoxanthine-guanine phosphoribosyltransferase activities in lymphocytes were identical in the two groups. In all subjects studied there were positive correlations between the erythrocyte adenosine deaminase activities, lymphocyte adenosine deaminase or deoxyadenosine activities, and plasma urate concentrations (P less than 0.05 in all cases), and between lymphocyte nucleoside phosphorylase and lymphocyte adenosine deaminase or deoxyadenosine deaminase activities (P less than 0.01 and less than 0.05, respectively). The results suggest that increased activities of some purine metabolizing enzymes found in both erythrocytes and lymphocytes may contribute to increased purine degradation and hyperuricemia in subjects with Down's syndrome. In addition, the increased adenosine deaminase and nucleoside phosphorylase activities may be related to the immunological dysfunction found in subjects with Down's syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943306     DOI: 10.1016/0885-4505(86)90105-2

Source DB:  PubMed          Journal:  Biochem Med Metab Biol        ISSN: 0885-4505


  5 in total

1.  Red blood cell metabolism in Down syndrome: hints on metabolic derangements in aging.

Authors:  Rachel Culp-Hill; Connie Zheng; Julie A Reisz; Keith Smith; Angela Rachubinski; Travis Nemkov; Eric Butcher; Ross Granrath; Kirk C Hansen; Joaquín M Espinosa; Angelo D'Alessandro
Journal:  Blood Adv       Date:  2017-12-21

2.  No Evidence for Mutations that Deregulate GARS-AIRS-GART Protein Levels in Children with Down Syndrome.

Authors:  Disha Banerjee; Debarati Ghosh; Anindita Chatterjee; Swagata Sinha; Krishnadas Nandagopal
Journal:  Indian J Clin Biochem       Date:  2012-01-06

3.  Homocysteine metabolism in children with Down syndrome: in vitro modulation.

Authors:  M Pogribna; S Melnyk; I Pogribny; A Chango; P Yi; S J James
Journal:  Am J Hum Genet       Date:  2001-06-05       Impact factor: 11.025

4.  Potential interaction between the GARS-AIRS-GART Gene and CP2/LBP-1c/LSF transcription factor in Down syndrome-related Alzheimer disease.

Authors:  Disha Banerjee; Krishnadas Nandagopal
Journal:  Cell Mol Neurobiol       Date:  2007-09-28       Impact factor: 5.046

Review 5.  Hyperuricemia in Children and Adolescents: Present Knowledge and Future Directions.

Authors:  Masaru Kubota
Journal:  J Nutr Metab       Date:  2019-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.